Axa’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.97M Sell
90,971
-18,023
-17% -$787K 0.01% 609
2025
Q1
$2.98M Sell
108,994
-142
-0.1% -$3.89K 0.01% 648
2024
Q4
$4.39M Sell
109,136
-176
-0.2% -$7.08K 0.01% 573
2024
Q3
$5.17M Buy
109,312
+33
+0% +$1.56K 0.02% 535
2024
Q2
$3.26M Buy
109,279
+62
+0.1% +$1.85K 0.01% 646
2024
Q1
$4.39M Buy
+109,217
New +$4.39M 0.01% 586